Newsroom

Biotechnology

Explore the latest breakthroughs and trends in the Biotechnology sector with our newsroom. From cutting-edge innovations in gene therapy and biopharmaceuticals to advancements in medical research and regulatory updates, we provide essential insights into the scientific developments shaping the future of healthcare and life sciences.


Latest Press Releases

Helix Biopharma Corp. Provides Polish Subsidiary Divestiture Update
BiotechnologyCompany Update

Helix Biopharma Corp. Provides Polish Subsidiary Divestiture Update

September 30, 2020 5:00 PM

RICHMOND HILL, ON / ACCESSWIRE / September 30, 2020 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced an update on the progress regarding the non-binding term sheet the Company received and previous announced on June 26, 2020 to divest the remaining shares it...

Read more
DECN Signs Agreement With US-Based Laboratory as Testing Partner for Genviro! Saliva Swift Kit Testing for Additional FDA, EU CE Mark and Russian Federation Submissions
BiotechnologyPartnerships

DECN Signs Agreement With US-Based Laboratory as Testing Partner for Genviro! Saliva Swift Kit Testing for Additional FDA, EU CE Mark and Russian Federation Submissions

September 30, 2020 9:15 AM

FDA & CLIA certified laboratory will begin the testing of the Genviro! 10.5 Sec. Saliva Swift Kit, with full results expected to be reported to regulators in USA, EU and Russian Federation, and will also be included in the Genviro! Swift package inserts LOS ANGELES, CA / ACCESSWIRE / September 30, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test...

Read more
Havn Life Sciences Inc. Reports Q1 Financial Statements
BiotechnologyCompany Update

Havn Life Sciences Inc. Reports Q1 Financial Statements

September 29, 2020 8:35 PM

VANCOUVER, BC / ACCESSWIRE / September 29, 2020 / Havn Life Sciences Inc. (CSE:HAVN) (FSE:5NP) (the "Company" or "Havn Life"), is pleased to announce Its financial results for the three month period ended July 31, 2020. Please note that all references to currency are in CDN dollars. First Quarter Results for three months ended July 31, 2020 - Financial highlights: The Company incurred net and comprehensive loss of $1,159,642 consisting...

Read more
Applied UV, Inc. Subsidiary, SteriLumen, Inc., Announces Filing of U.S. Patent Application for a System to Neutralize Pathogens on Physical Surfaces
BiotechnologyCompany Update

Applied UV, Inc. Subsidiary, SteriLumen, Inc., Announces Filing of U.S. Patent Application for a System to Neutralize Pathogens on Physical Surfaces

September 29, 2020 8:30 AM

Sterilumen patent-pending UV Light sanitizing solution designed to be retrofitted to Bank ATMs to automatically disinfect surfaces on an ATM machine, including a keyboard, touchscreen, credit card reader between uses MOUNT VERNON, NY / ACCESSWIRE / September 29, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC")...

Read more
EV Biologics To Perform Specialized Analysis of EV Biopharmaceuticals at Vanderbilt University
BiotechnologyCompany Update

EV Biologics To Perform Specialized Analysis of EV Biopharmaceuticals at Vanderbilt University

September 29, 2020 8:00 AM

CHEYENNE, WY / ACCESSWIRE / September 29, 2020 / EV Biologics, Inc. formerly Yulong Eco-Materials Limited (OTC PINK:YECO) today announced that it intends to utilize the advanced instrumentation and research staff at the Vanderbilt Institute of Nanoscale Science and Engineering (VINSE) and the Vanderbilt Center for Structural Biology (CSB) in the development of extracellular vesicle (EV)-based diagnostics and therapeutics. Founded in 1873,...

Read more
Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTECH Technology in Delivering Antiviral Drugs
BiotechnologyCompany Update

Lexaria Receives Conditional Ethics Board Approval for Pilot Human Study Using DehydraTECH Technology in Delivering Antiviral Drugs

September 29, 2020 6:25 AM

Company Raises Commitment to Antiviral Research with Launch of Rodent Antiviral Drug Delivery Study with Potential COVID-19 Applications KELOWNA, BC / ACCESSWIRE / September 29, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today provides an update on a previously announced antiviral research initiative and introduces a new research project with potential...

Read more
SCEMFIS Research Provides New Insights on Gray Seals; Suggests Alternatives to Current Management
BiotechnologyCompany Update

SCEMFIS Research Provides New Insights on Gray Seals; Suggests Alternatives to Current Management

September 28, 2020 4:45 PM

OCEAN SPRINGS, MS / ACCESSWIRE / September 28, 2020 / Decades of strict conservation and management have led to a rebound of gray seals in the North Atlantic. Now, research from the Science Center for Marine Fisheries (SCEMFIS) is providing new insights into this population, how local fisheries interact with them, and better options to manage them. The study, led by Drs. Doug DeMaster, Paula Moreno, Andre Punt, and John Brandon of the...

Read more
Molecular Partners Presents Preclinical Data Supporting Tumor Localization Mechanism of its CD40 Agonist MP0317 at World Bispecific Summit
BiotechnologyInvestor Relations

Molecular Partners Presents Preclinical Data Supporting Tumor Localization Mechanism of its CD40 Agonist MP0317 at World Bispecific Summit

September 24, 2020 12:00 PM

MP0317 activates multiple antitumor immune cell types in vitro when in the presence of tumor stroma associated FAP MP0317 mouse surrogate localizes to FAP-expressing tumors and induces strong and durable anti-tumor responses without systemic toxicity, and demonstrates strong anti-tumor immune memory responses ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / September 24, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech...

Read more
OPTEC International, Inc. (OPTI) Secures $5,000,000 + Financing for Expansion of UV-C Sterilization Products to Help Safely Re-Open Economy Amidst Increased Pandemic Case Reports
BiotechnologyCompany Update

OPTEC International, Inc. (OPTI) Secures $5,000,000 + Financing for Expansion of UV-C Sterilization Products to Help Safely Re-Open Economy Amidst Increased Pandemic Case Reports

September 24, 2020 8:00 AM

CARLSBAD, CA / ACCESSWIRE / September 24, 2020 / OPTEC International, Inc (OTC PINK:OPTI) today announced that it has secured a $5,000,000+ funding approval with California based RB Capital Partners, Inc. ("RB Capital"). RB Capital has agreed to provide funding to the Company in the form of premium to market 12 month promissory notes. The minimum amount of funding that RB Capital has agreed to provide to the Company under these terms is...

Read more
Integrated BioPharma Reports Results for its Fiscal Year Ended June 30, 2020
BiotechnologyEarnings

Integrated BioPharma Reports Results for its Fiscal Year Ended June 30, 2020

September 23, 2020 5:25 PM

HILLSIDE, NJ / ACCESSWIRE / September 23, 2020 / Integrated BioPharma, Inc. (OTCQB:INBP) (the "Company" or "INBP") reports its financial results for the fiscal year ended June 30, 2020. Revenues for the fiscal year ended June 30, 2020 were $52.8 million compared to $50.0 million for the fiscal year ended June 30, 2019, an increase of $2.8 million or 5.6%. The Company had operating income for the fiscal year ended June 30, 2020 of $3.3 million...

Read more
Yulong to List its Securitized Token on CryptoSX
BiotechnologyCompany Update

Yulong to List its Securitized Token on CryptoSX

September 23, 2020 8:35 AM

CHEYENNE, WY / ACCESSWIRE / September 23, 2020 / Yulong Eco-Materials Limited / EV Biologics, Inc. (OTC PINK:YECO) today announced that it intends to list its Securitized Token Offering "STO" on the CryptoSX digital exchange. CryptoSX is a fully licensed and regulated Digital Assets Exchange that allows issuers to tokenize and investors to buy and sell digital assets including assisting issuers to securitize assets, such as public company...

Read more
Nascent Biotech Research Collaboration Partner, Manhattan BioSolutions, Receives Grant for Covid 19 Vaccine Studies.
BiotechnologyCompany Update

Nascent Biotech Research Collaboration Partner, Manhattan BioSolutions, Receives Grant for Covid 19 Vaccine Studies.

September 23, 2020 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / September 23, 2020 / Nascent Biotech, Inc (OTCQB:NBIO), a biotechnology company pioneering innovative medicines to overcome difficult-to-treat cancers and viral infections, announces that its collaboration partner, Manhattan BioSolutions, has been awarded a Phase I SBIR grant by the National Science Foundation (NSF) entitled "Genetically Engineered BCG as a Microbe-Based Platform for Vaccination Against...

Read more
Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine
BiotechnologyPartnerships

Mymetics Starts Preclinical Studies with Baylor College of Medicine for Virosome-based Covid-19 Vaccine

September 23, 2020 6:00 AM

Mymetics has started a Covid-19 vaccine development project based on Mymetics' virosome vaccine carrier platform, which will evaluate different rationally designed SARS-CoV-2 antigens for an effective and safe virosome-based Covid-19 vaccine. In May 2020 Mymetics and Baylor College of Medicine in Texas signed a Research Agreement to preclinically produce and test virosomes incorporating SARS-CoV-2 recombinant proteins. As part of the...

Read more
American CryoStem Announces: FDA has cleared its Investigational New Drug (IND) for Post-Concussion Syndrome for Phase I Clinical Trial
BiotechnologyProduct Announcements

American CryoStem Announces: FDA has cleared its Investigational New Drug (IND) for Post-Concussion Syndrome for Phase I Clinical Trial

September 23, 2020 6:00 AM

EATONTOWN, NJ / ACCESSWIRE / September 23, 2020 / American CryoStem Corporation (OTC PINK:CRYO) is a clinical stage biotechnology company, global licensor, and a pioneer in autologous cellular therapy processing. The Company has developed proprietary products and services to advance its end-to-end personalized cellular therapy platform consisting of the collection - processing - cryobanking - return to point-of-care of adipose tissue and...

Read more
Wuhan General Group Corporate Update on Tsime Pharmaceuticals Acquisition
BiotechnologyCompany Update

Wuhan General Group Corporate Update on Tsime Pharmaceuticals Acquisition

September 22, 2020 9:05 AM

CAPE TOWN, SA / ACCESSWIRE / September 22, 2020 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is delighted to share the following corporate updates: Tsime Pharmaceuticals The last step in completing the due diligence regarding the acquisition of Tsime Pharmaceuticals Inc. ("Tsime") was accomplished last week with the visit...

Read more
Applied UV, Inc. Subsidiary, SteriLumen, Inc., Announces Receipt of Purchase Order for Airocide(TM) Air Quality-Improvement(TM) System from Dubai Creek Golf & Yacht Club Resort
BiotechnologyCompany Update

Applied UV, Inc. Subsidiary, SteriLumen, Inc., Announces Receipt of Purchase Order for Airocide(TM) Air Quality-Improvement(TM) System from Dubai Creek Golf & Yacht Club Resort

September 22, 2020 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / September 22, 2020 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") utilizing its patented devices to destroy pathogens safely, thoroughly, and automatically, today announced that its subsidiary, SteriLumen, Inc. ("SteriLumen"), together with its distribution partner for the United Arab...

Read more
OPTEC International, Inc. (OPTI) Introduces UV & UV-C  Hydroxyl Air Purifier Solutions for Commercial and Personal Applications
BiotechnologyCompany Update

OPTEC International, Inc. (OPTI) Introduces UV & UV-C Hydroxyl Air Purifier Solutions for Commercial and Personal Applications

September 22, 2020 8:00 AM

CARLSBAD, CA / ACCESSWIRE / September 22, 2020 / OPTEC International, Inc (OTC PINK:OPTI) today announced that the Company now has a suite of air purification products that effectively kills 99.99% of virus, bacteria, germs, and other harmful contaminants based on SGS testing (the world's leading inspection, verification, testing and certification company). Specifically, the Optec Hydroxyl Air Sterilizer is safe to use while children and adults...

Read more
Aqualung Therapeutics Corp. Awarded $300 Thousand From National Institute of Health (NIH) to Develop a Novel Therapeutic for Pregnant Women at Risk for Preterm Births
BiotechnologyCompany Update

Aqualung Therapeutics Corp. Awarded $300 Thousand From National Institute of Health (NIH) to Develop a Novel Therapeutic for Pregnant Women at Risk for Preterm Births

September 22, 2020 7:45 AM

TUCSON, AZ / ACCESSWIRE / September 22, 2020 / Aqualung Therapeutics, an early-stage biotech company developing an immune-focused, anti-inflammatory therapeutic platform for unchecked inflammation in patients with serious acute and chronic diseases, has been awarded a one year NIH FAST-TRACK AWARD (1R41 HD101202-01A1) to support development of a humanized antibody therapy for pregnant women with intrauterine infection at risk for preterm...

Read more
Experion Partners with Leading National Sales Agency, Velvet Management
BiotechnologyPartnerships

Experion Partners with Leading National Sales Agency, Velvet Management

September 21, 2020 8:45 AM

VANCOUVER, BC / ACCESSWIRE / September 21, 2020 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce a partnership with Velvet Management Inc. ("Velvet"), to be its national sales and distribution agent for its premium craft cannabis brand, Citizen Stash, to be sold through provincially licensed stores across Canada. Velvet is a leading full-service cannabis marketing agency...

Read more
Yulong to Issue the Worlds’ First Biotech Securitized Token Offering
BiotechnologyCompany Update

Yulong to Issue the Worlds’ First Biotech Securitized Token Offering

September 21, 2020 8:30 AM

CHEYENNE, WY / ACCESSWIRE / September 21, 2020 / Yulong Eco-Materials Limited / EV Biologics, Inc. (OTC:YECO) today announced that it intends to issue a Securitized Token Offering "STO" to raise funding for research and development - a world's first. Security Token Offering (STO) YECO/EV Biologics is preparing to launch the first ever Securitized Token for cell-based therapy/biological drug development. This move will revolutionize...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?